***This event has now ended. For future event opportunities, please contact us (details at the bottom)***
The Changing Face of Clinical Trials: Patient Centricity, Data and Technology
Join us at the world’s biggest business festival, backed by the UK government. The International Business Festival (IBF) is a true celebration of the dynamism and diversity of the global market place.
We will be hosting the annual bioConclave during the Life Sciences week at the IBF on 26 June 2018. Alongside our event, you will also have chance to explore other exclusive life sciences events taking place on the same day at the IFB Festival and have the chance to meet over 1,000+ life science companies over one day.
About the event
The bioConclave gathers leaders together from across pharma, biotech, healthcare and academia for the perfect blend of high quality presentations and intimate networking.
Technology and data are at the forefront driving clinical trial decision making. With further advancements in new technologies (such as mobile devices and wearables) and the rise of online communities, the pharma and biotech industries are poised to capitalise on these advancements to innovate existing clinical trial processes and systems. Additionally, we will feature best practices and case studies on successful patient engagement, recruitment techniques using novel, patient-centric and data-driven approaches.
We will look to explore the question “What is the future of clinical trials?”
The bioConclave has built a reputation as being the leading platform for UK and European life sciences companies to meet exciting innovators from around the world in the area. Read more about the inaugural bioConclave 2015, the second edition of bioConclave in 2016 and the third edition in 2017. In this period, we’ve been covered in The Guardian, City AM, Yorkshire Post, Economic Times and elsewhere. Past speakers have include Sir Malcolm Grant (Chairman, NHS England), Sir Alan Markhan (former CEO, Cancer Research UK), Harriet Fear (former CEO, One Nucleus), Hitesh Thakrar (Partner, Syncona Investment Management) and Charlie Davie (Managing Director, UCLPartners).
Who should attend?
This event brings together executive-level professionals from pharma, biotech, CROs, healthcare, academics and solution providers from across Europe. The audience will hear views from clinical research industry leaders, see new technologies in the exhibition demonstrations, and meet and network with leading researchers, industry leaders and innovators.
Why attend?
The 2018 International Business Festival is set to attract around 3,000 delegates a day, creating huge opportunities for business-facing brands to showcase themselves and their offer direct to forward-thinking business people.
As a delegate, network and meet new potential business partners.
As a conference speaker, throw a spotlight on your cutting-edge solutions changing the face of clinical trials.
As a sponsor, position your company as a leader within the pharma and biotech industry.
As an exhibitor, discover how to showcase your company to the right audience by exhibiting at the IBF over three days
The IBF dedicated B2B meeting platform will allow you to directly reach out to your potential clients directly.
The event will be taking place at: Exhibition Centre Liverpool, Kings Dock, Liverpool L3 4FP. This is a multi-million pound exhibition and events complex that accompanies ACC Liverpool on the former King's Dock in Liverpool, England.
Get in touch
what others had to say
Dr Saumya S. Jamuar Visiting Scientist at Harvard Medical School & Chief Scientific Officer, Global Gene Corp, “We are delighted to announce this strategic collaboration, which will deliver cutting‐edge personalised chemotherapy to cancer patients in India. Research has indicated that up to 75% of chemotherapy drugs as a class are ineffective, and our combined proposition of personalised chemotherapy, in which optimal drugs are identified for each patient using specialised testing before treatment is commenced, could have a game‐changing impact.”
Dr Anil Wali Managing Director, FITT, Indian Institute of Technology - Delhi “It is wonderful to be in London for the bioConclave. Forums such as these bring a practical perspective to bringing SMEs, big pharma, innovators and investors together.”
May 17, 2018The Royal Institution, 21 Albemarle St, Mayfair, London W1S 4BS
***This event has now ended. For future event opportunities, please contact us (details at the bottom)*** What does innovation mean to you? This half-day workshop brings together a global community of in-house counsel together with company secretaries, compliance professionals, CxOs and other innovators to…
January 23, 2018Beveridge Hall, Senate House, University of London, Malet Street, London, WC1E 7HU, UK
***This event has now ended*** "Education Innovation" could mean something different for an educator, a technologist, a corporate and for students. In this constantly evolving sector, we must find ways to accommodate changes in institutional demands, demographics, technology, student needs, pedagogical trends, political pressures, employability…
***This event has now ended. For future event opportunities, please contact us (details at the bottom)*** Are you a successful Indian business looking to expand overseas? Are you curious about the opportunities the US market offers? Would you like to speak to experts flying in…
Michael Mullane Innovation Lead (NIHR Clinical Research Network)Website
Bio
Michael Mullane has worked in digital for over 25 years. Mick has a track record in delivering innovative solutions built on technology, from working with some of the first educational broadband and networks in the 1990’s, to early online and social learning systems in the 2000’s. pioneering the use of SMS text, podcast solutions 10 years ago to a more recently leading the shift of the NIHR onto a collaborative cloud based computing platform, and designing the first NIHR research ‘app’ involving a complete consent process.
Mick is a firm believer in the ability of technology to provide an individual with more choice, facilities and importantly more control over their own lives, personal networks and data.
Mick is currently working to bring ‘apps’ into mainstream research, to give the patient and participant a greater voice in research, and to connect researchers and patients to the right research. With a strong belief in putting the patient at the very centre of the experience.
Mick lives on the Yorkshire Coast and can be found either on a bike, on a boat, or walking his dog, Bramble.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
1:40 pm - 2:05 pm
Talk 5: NIHR Case Study: Strategizing for eConsent Across Clinical Research
The UK’s NIHR has conducted a proof of concept trial for obtaining patient consent via mobile devices. Plans are underway to develop this concept work further. In this session, hear from Michael Mullane on: ▪ Developing the vision ▪ Factors considered prior to launch ▪ Implementation strategy ▪ Lessons learned ▪ What comes next? The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Zeshan Ghory Vice President of Strategy (Antidote)Website
Bio
Zeshan Ghory is Vice President of Strategy at Antidote, the online platform for matching patients to clinical trials. A major part of his role is taking a data-driven approach to measure and deliver successful outcomes for patients, trial sponsors and partners.
He has over 15 years experience building and investing in technology and data solutions across Europe, Japan, and the US, including projects for several leading life science companies such as Novartis, Eli Lilly, AstraZeneca, and Baxter Healthcare.
Zeshan has a degree in Mathematics from Imperial College, London and an MBA from INSEAD, France.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
10:45 am - 11:10 am
Talk 3: Are trial sites ready for online patient recruitment?
When it comes to online patient recruitment, the site-patient handover is critical and in this talk, we will examine a case where Antidote was able to identify that sites in a certain study were underperforming compared to our usual benchmarks. Further investigation unveiled several problems at the site level that were causing patients to drop out of the recruiting process. After addressing these we saw an immediate improvement in the conversion funnel. We will also discuss how data-driven analysis can be used to optimise patient flow to the best-performing sites. Key takeaways: ▪ Understand your baseline for normal performance so you can spot anomalies ▪ Patients coming via online channels will have certain expectations for speed of response ▪ Use your data to back your winners (high performing sites) The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
James Batchelor Director Clinical Informatics Research Unit, Faculty of Medicine (University of Southampton)Website
Bio
Professor James Batchelor is the Professorial Fellow of Clinical Informatics and Healthcare Innovation at the University of Southampton. He is also the Director of the Clinical Informatics Research Unit and the EDGE Programme, which is a collaborative group of NHS hospitals and research organisations working together to support and improve the Research and Development process through the development of the EDGE Software. James is also a Committee member and advisor to the Republic of Ireland e-Health Programme as well as being involved in the development of clinical research standards, Genomics and Integrated BioMedical Informatics Platforms. James has worked in this area of research for over 19 years and is well-known within the research community, both in the United Kingdom and overseas.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
12:00 am - 12:10 am
Capacity and capability of global clinical research- The challenge of the unmet need of collaboration
Monitoring and delivery are key objectives to running efficient trials for industry and academic sponsors. Globally these remain a challenge due to siloed data, processes and lack of real-time collaboration. The need to step back and look at these problems and interactions are going to be key to speed the drug discovery process and to be able to react to pandemic challenges. How has the University of Southampton challenged the norm and developed a collaborative approach to clinical research across 80% of the NHS and Canada to shift the way sites and sponsors work together, underpinning clear and effective research management?
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Graeme Chapman Health and Life Sciences Industry Solutions Executive (Microsoft)LinkinWebsite
Bio
Graeme Chapman is an experienced industry solutions professional delivering digital transformation to healthcare and pharmaceutical organisations in the UK.
Graeme also has experience in Central Government, Retail Banking, Insurance, Manufacturing and Utilities.
Graeme holds a Masters degree in Engineering and post graduate qualifications in Management and Marketing.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
2:05 pm - 2:30 pm
Talk 6: Democratizing AI for better outcomes
The presentation will showcase how systems of intelligence can deliver personalised medicine and accelerate the process of clinical trials. It will also explore how systems of engagement can enhance adherence, manage chronic conditions and prevent disease.
The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Rupert Coghlan Head of Insight (uMotif)LinkinWebsite
Bio
Rupert is Head of Insight at uMotif and has lead analytics projects across many different industries including digital health, media, public sector and financial services. He has a wide range of experience covering technologies for data mining, visualisation and programming and has a passion for making complex data analysis accessible.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
11:20 am - 12:00 am
Case Study: Performing large-scale patient-centric real-world evidence-based research
Health research is going through a period of rapid change driven by the increased understanding that the patient needs to be seen as more than just a source of data. Rapid digitisation is helping to increase patient engagement around their healthcare and at a higher level become partners in the drive towards improved medications and equally important ongoing collaborators all the way from clinical trials into the real world. This session will look at: ▪ The growing importance of Real World Evidence and why this will start to become a continuum flowing from the clinical trial process ▪ The growing importance of digital approaches as a technology foundation for research with examples from recent case studies in areas such as Parkinson's ▪ The increase in the usage of patients own devices combined with sensors to drive both an individual's understanding of their health and to capture data for use in research The talk will be followed by 5min audience Q&A.
Steph is Operational Accounts Manager at uMotif. Previously she has worked in the NHS within psychological therapies and in account management across advertising, market research and a technology startup within the healthcare industry.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
11:20 am - 12:00 am
Case Study: Performing large-scale patient-centric real-world evidence-based research
Health research is going through a period of rapid change driven by the increased understanding that the patient needs to be seen as more than just a source of data. Rapid digitisation is helping to increase patient engagement around their healthcare and at a higher level become partners in the drive towards improved medications and equally important ongoing collaborators all the way from clinical trials into the real world. This session will look at: ▪ The growing importance of Real World Evidence and why this will start to become a continuum flowing from the clinical trial process ▪ The growing importance of digital approaches as a technology foundation for research with examples from recent case studies in areas such as Parkinson's ▪ The increase in the usage of patients own devices combined with sensors to drive both an individual's understanding of their health and to capture data for use in research The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Sarah Cooper Business Development Manager (NIHR Clinical Research Network)Website
Bio
Sarah Cooper is the Business Development Manager (Commercial) for the NIHR Clinical Research Network. Sarah facilitate key discussions between industry and Clinical Research Network and Sarah is a point of contact for life sciences companies engaging with the Clinical Research Network. Sarah provide advice to companies on how they are able to tap in to the Clinical Research Network services to ensure clinical studies are set up quickly, efficiently and ensure they recruit to time and target.
With a degree in Medical Biochemistry, Master in Human Nutrition and PhD in Clinical Nutrition Sarah Cooper has worked with the Clinical Research Network for the past 6 years. Sarah’s first role with the network was to support the national clinical leads across a range of therapeutic areas. Prior to working with the network Sarah worked as a Clinical Researcher for over 10 years delivering a range of studies in both community and hospital settings. Sarah has several peer review published articles.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
3:50 pm - 4:15 pm
Talk 9: Entering a new era of clinical trials: Beyond the hospital
The clinical research landscape in which we work is rapidly evolving. Patient centricity. Digital revolution. Real-world evidence. These are just a few hot topics which require the clinical research community to think differently about how and where we might deliver clinical research in the future. In the UK, most clinical research has traditionally taken place within our or National Health Service (NHS), be that primary or for the National Institute of Health Research and a change in government policy in November 2017 has extended the UK clinical research environment beyond the NHS. This presentation will:
▪ Describe how policy change has enabled support for clinical research and public health research projects conducted in non-NHS settings such as prisons, care homes, hospices, schools and other community settings
▪Explain how the network approach in the UK is implementing this change and ensuring that the right research is delivered in the most appropriate setting, to drive better outcomes for patients
▪ Showcase case study examples of clinical research that is already happening outside the hospital in areas such as in pharmacy, ambulances, care homes
Learning outcomes- The audience will:
▪ Gain an understanding of the expanding clinical research environment in the UK
▪ Be able to recognise where opportunities for innovative clinical trials might lie, outside of traditional settings
▪ Develop their understanding of the clinical research support mechanisms that are in place in the UK to enable and facilitate both commercial and non-commercial clinical trials and studies and understand how to access them
The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
Gemma Estrada Bertran Director Digital Health & Technology (Ferrer)LinkinWebsite
Bio
Gemma Estrada Bertan is an Executive with solid background in Clinical Research as well as in Science who is committed to reimagine Pharma companies by leveraging “digital” on behalf of patients, doctors, payers, partners and employees to make sustainable impact on healthcare. Gemma is happy to bridge and integrate different cultural environments for transnational projects. Gemma has the ability to drive the vision, enhance performance and effectively frame problems when they arise. Gemma relate to all team members, build trust and create the right spirit that ultimately allows the project to thrive. Currently, Gemma is Director Digital Health and technology at Ferrer, a privately owned pharmaceutical and chemical company headquartered in Barcelona. Previously, Gemma developed the Harrison Clinical Research operation (HCR) in Spain and was its Managing Director during 12 years. Following the merger of Synteract, Inc with HCR, Gemma grew into the position of Regional Director of South Europe, Israel and Latin America. Gemma’s major professional achievement was the establishment of the legal and financial infrastructure to operate in Argentina and Spain where we enabled 11 years of continuous growth. Past experience also includes managing the Barcelona Clinical Trials Platform (BCTP), a strategic instrument promoted by the Health Department of the Catalan Government to strengthen clinical research capacity in the region. As a young professional Gemma was monitor and project manager at J. Uriach & Cía (1995-1997) and Sanofi (1997-2000), as well as a research fellow at the Universitat de Barcelona (1989-1991), at the New England Medical Center -Tufts university, Boston, MA, (1992-1994), and an invited researcher at the Academish Medish Centrum – Universitat van Amsterdam (1993). With regards to publications Gemma has contributed 20 articles in peer review journals and non indexed magazines. Gemma cultivate an active network of relationships across multiple organizations and academia.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
12:20 pm - 12:40 pm
CUIDA-M: An app for caregivers designed by caregivers in mental health
The talk will be followed by 10 min audience Q&A
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Sally Rennison Business Development and Procurement Lead (Patients Know Best®)Website
Bio
With 5 years experience in electronic patient records, Sally moved to Patients Know Best to join a more patient centric company. As part of the Business Team at PKB she is am responsible for business growth and retention for Scotland, the North West, West Midlands and Wales . Sally also oversees all procurement activities within the organisation.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
2:30 pm - 2:55 pm
Talk 7: Patients know best - the patient revolution
As a social enterprise, Patients Know Best (PKB) developed the world’s first patient-controlled medical records platform which is now recognised as a leading Integrated Digital Care Record (IDCR) and patient portal designed for borderless sharing of information, both of which can be used independently or in combination. The platform encourages self-management via care management and patient engagement tools. Information can be added via consumer devices, or manually entered. Health and care organisations can then make use of this data, adding it to their own records, designing new pathways and performing analytics to improve the quality and decrease the cost of healthcare.
Learning outcomes: ▪ Why we should put the patient at the centre ▪ How we can reduce the cost of services through digitisation ▪ How borderless care can and is being achieved
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Elin Haf Davies Founder/ CEO ( Aparito)LinkinWebsite
Bio
Dr Elin Haf Davies has combined her career in paediatric health and her passion for sport and extreme adventure.
Elin Haf Davies began her career as a Paediatric Nurse at Great Ormond Street Children’s Hospital in London before going on to gain a PhD from University College London. After eight years of clinical experience Elin moved to research and spent six years managing clinical and academic drug trials, in metabolic, neurology, endocrinology and pain. Her PhD was based on the development of age-appropriate and disease specific biomarkers and clinical endpoints in neurometabolic, with a focus on ataxia and gait.
In 2007 Elin moved to work at the European Medicine Agency Paediatric Team where, amongst other projects she evaluated over a 100 Paediatric Investigation Plans of drug trials in children during her six years there.
In 2014 Elin founded aparito – a digital health social enterprise using wearable technology and smart phone apps to monitor patients remotely.
In her free time Elin has a passion for extreme adventure to raise money for charities close to her heart. In 2007-2008 she rowed across the 2600 miles across the Atlantic Ocean, raising £190,000 for metabolic research at Great Ormond Street Hospital. Money that funded a PhD project that identified the value of Vitamin B6 for managing neonatal seizures, an area that Elin is now actively supporting in her professional capacity.
In 2009 Elin was part of the first all female crew to ever row across the Indian Ocean. The 3500 miles took 78 days to complete, but secured a place for the girls in the 2011 Guinness Book of Records. The challenge also raised over £26,000 for Breast Cancer Care.
In 2012 Elin completed her hat-trick of oceans by sailing 6000 miles across the north Pacific, in 30 days. This time raising money for Noah’s Arch that aims to establish the first children’s hospital in Wales.
Elin’s adventures over the years have raised over £250,000 for charities. She has been acknowledged by the Welsh Assembly for Services to Wales, published an honest and gritty account of her experiences “On Tempestuous Seas”, and was selected to carry the 2012 Olympic Torch.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
3:25 pm - 3:50 pm
Talk 8: Digital patient and digital biomarker
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Petra Jantzer Managing Director (Life Science Organization, Accenture)LinkinWebsite
Bio
Dr. Petra Jantzer is a Managing Director in Accenture’s Life Science Organization.
Petra Jantzer is the CEO for LifeSciences in Germany, Austria, and Switzerland, responsible for Accenture’s global services to our Pharmaceuticals and MedTech clients based in this geography. Petra also leads our European Accelerated R&D Services, helping our clients across the world to bring cutting edge innovation to patients in need.
Petra has more than 20 years’ experience in R&D, both as a consultant in the (bio)pharmaceuticals sector and as a researcher. Petra combines profound industry and R&D knowledge, deep business process understanding, and more than a decade of C-level counseling experience to help clients (digitally) transform their businesses.
Petra holds a PhD in immunology and an honors degree in molecular biology.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
9:25 am - 9:50 am
Talk 2: The Digital Clinical Trial
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Urvashi Prasad Public Policy at Niti Aayog, Office of Vice Chairman (Niti Aayog, Government of India)LinkinWebsite
Bio
Urvashi Prasad is a public policy specialist at NITI Aayog, the Indian Government’s premier think tank. She is also the founder of Every Voice, a platform that highlights the perspectives, needs, challenges and aspirations of people living in poverty in their own words. Urvashi was previously a Director at Operation ASHA, one of India’s largest tuberculosis control NGOs. She also led the health portfolio of the Michael & Susan Dell Foundation in India for five years. Urvashi is on the governing board of Partnership for TB Care & Control, the largest tuberculosis network in India. She completed her Bachelors in Genetics from University of Birmingham, UK, followed by a Masters in Bioscience Enterprise from University of Cambridge, UK and a Masters in Public Health from the London School of Hygiene & Tropical Medicine. Urvashi is passionate about gender-related and animal welfare issues. She is also a blogger and writes extensively for several platforms including the Huffington Post and Nextbillion.net.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
9:00 am - 9:25 am
Talk 1: The evolving role of technology and data in health research: Challenges and Opportunities
Health research is undergoing a significant transformation with the emergence of new technologies and increasing avenues for use of big data analytics and artificial intelligence. This talk will highlight the developments on this front in India, including some case studies as well as outline the key opportunities and challenges, especially from a policy and regulatory perspective. The talk will be followed by 5min audience Q&A
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Professor S.S. Vasan Honorary Visiting Professor, University of York; Senior Business Development Manager, Public Health England ()Linkin
Bio
Professor S.S. Vasan is Senior Business Development Manager for Public Health England (PHE), and prior to that for the Health Protection Agency. A former McKinsey Consultant and Rhodes Scholar, he is also Honorary Visiting Professor of Health Sciences at the University of York, and Adjunct Professor of Preventive and Social Medicine at JIPMER, an ‘Institution of National Importance’ in India. Before joining public service, he was Head of Public Health for Oxford University’s spin-out company Oxitec Limited, which was recently acquired for $160m.
Dr Vasan is PHE’s business development lead for global health, innovation and international consultancy, as well as for Ebola- and Zika-related activities. For the latter, he received the RCUK Impact Award 2015 and the British Expertise International Award 2018, on behalf of his team. He represents PHE’s overseas commercial engagement in the UK InterLab Forum and is a member of the Antiviral Task Group of the Australia-Canada-UK-US Medical Counter-Measures Consortium, and the Five Eyes BSL4 Laboratories Network (in which he also the co-chairs International Response Working Group). He obtained his doctorate from Trinity College, Oxford, and is a Fellow of the Royal Society of Medicine, Royal Entomological Society, Royal Society for Public Health and the Chartered Management Institute.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
11:10 am - 11:35 am
Talk 4: Gathering data when human clinical trials are unethical or infeasible
Clinical efficacy trials in people are not always feasible or ethical, thus hampering the development and testing of countermeasures for lethal or permanently disabling toxic agents (e.g. chemical, biological, radiological or nuclear substances). This talk will give a quick overview of how the FDA Animal Efficacy Rule overcomes this problem and examples of life- saving animal models for emerging infectious diseases such as Ebola. The case study will be presented on collaboration between academic, non-profit, public and private sector organisations to combat recent emergencies such as Ebola and Zika. The talk will be followed by 5min audience Q&A.
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Dr Maruthi Viswanathan CEO (RxPrism Health Systems)LinkinWebsite
Bio
Dr Maruthi Viswanathan is the Founder and Chief Executive Officer of a digital startup RxPrism Health Systems located in the Silicon Valley of India. A physician by education, Dr Maruthi is a dynamic visionary with international expertise in scientific education, medico-marketing communication, medical simulations, mobile applications, and innovative healthcare systems for patients and healthcare providers alike. Dr Maruthi has developed a unique 3-D software for scientific visualization and has several copyrights to his credit. An innovator par excellence, he has ideated, designed, and deployed a multitude of digital options for the top pharmaceutical companies worldwide.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
12:10 am - 12:20 pm
AI enabled BOTs for patient education & assistance
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
Andrew Fried Global Industry Leader, Life Sciences (IBM)Website
Bio
Andrew Fried is IBM Life Sciences Leader for Europe.
Andrew helps clients address industry imperatives and save lives through the power of cognitive insights. He works with clients to advance the next generation of discovery and development, acting on insights to drive value, enhance relationships across the ecosystem and empowering people to make better decisions.
Prior to transferring to Europe in July 2015, Andrew was IBM’s Life Sciences Leader for China. While in China Andrew worked with many leading multi-national companies and several Chinese Life Sciences companies who were leaders in their respective segment.
Before joining IBM in 2000, Andrew had a successful 14-year career with a leading strategy consulting company. He graduated from Melbourne University with a Bachelor of Arts, and Monash University (Melbourne, Australia) with a Bachelor of Business. Andrew has a Masters of Business Administration from the International University of Japan and is a Fellow of the Financial Services Institute of Australasia. He was a three-term board member on a government enterprise with assets of over $350M. He was a founding director of a successful dot.com start-up in the early 2000s.
Andrew is an advocate of sport and fitness as a gateway to good health. He is passionate about the role of genomics in identifying both the cause of disease and personalized solutions.
Sessions
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
June 26, 2018
9:40 am - 10:10 am
Case Study: Artificial intelligence in life sciences: Giving data life
Ageing populations, longer life expectancy and increasing multi-chronic disease prevalence compound cost burdens on our societies. At the same time, new technologies drive exponential change and opportunity into an industry crucial to societies, yet slow to adapt and alarmingly vulnerable to attacks and disruption. Advancements in genomics, proteomics, metabolomics create new thresholds in innovation.
Meanwhile, the rising voice of the consumer is empowering individuals and in response, new players are entering and reshaping the industry.
For industry, processes, models and structures must be reinvented within and across entities and industry itself must eliminate inefficiencies and reduce waste in the system.
Therefore, there is a persistent drive to understand and deliver value, focused on improving efficiencies, increasing automation and reducing variability. To do this industry members must deploy a robust data strategy and leverage enterprise data to drive services and engagement to deliver the best to populations managed.
